- Research works
- 27 ▲ 7% vs 2013–17
- Citations
- 627 22.9 per fractional work
- Top-10% rate
- 10.2% record average 16.5%
- Open access
- 27% world 28%
Not ranked overall: Ipsen (Spain) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which keywords describe research at Ipsen (Spain)?
By fractional works in all years, weighted toward what it does more of than the world: Chemotherapy, Genetic Mutations, Genetic Variants, Cancer, Immunotherapy, Biomarkers, Growth Hormone and Neurological Disorders.
- Topoisomerases
- DNA
- Signaling
- Prostate Cancer
- Botulinum Toxin
- Quality of Life
- Cardiovascular Disease
- Neurological Disorders
- Clinical Trials
- Immunotherapy
- Genetic Variants
- Cancer
- Chemotherapy
- Genetic Mutations
- Biomarkers
- Treatment
- Growth Hormone
- Nuclear Receptors
- Clinical Guidelines
- Oxidative Stress
- Neurotoxins
- Receptor
- Breast Cancer
- Estrogen
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 24 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 24 words, with their numbers
- Chemotherapy3▲ 15×5 topics
- Cancer2▲ 5.5×7 topics
- Genetic Mutations2▲ 14×5 topics
- Genetic Variants2▲ 32×3 topics
- Biomarkers2▲ 9.4×4 topics
- Immunotherapy2▲ 8.9×4 topics
- Treatment2▲ 4.1×3 topics
- Clinical Trials1▲ 8.0×5 topics
- Growth Hormone1▲ 60×2 topics
- Neurological Disorders1▲ 7.5×2 topics
- Nuclear Receptors1▲ 27×2 topics
- Cardiovascular Disease1▲ 4.4×5 topics
- Clinical Guidelines1▲ 15×4 topics
- Quality of Life1▲ 3.6×5 topics
- Oxidative Stress1▲ 2.4×5 topics
- Botulinum Toxin1▲ 60×1 topic
- Neurotoxins1▲ 82×1 topic
- Prostate Cancer1▲ 28×3 topics
- Receptor1▲ 54×2 topics
- Signaling1▲ 35×3 topics
- Breast Cancer1▲ 13×1 topic
- DNA1▲ 121×1 topic
- Estrogen1▲ 50×1 topic
- Topoisomerases1▲ 121×1 topic
Which research topics does Ipsen (Spain) publish most on?
By volume in 2022–2025: Stroke Rehabilitation and Recovery, Botulinum Toxin and Related Neurological Disorders, Cultural Industries and Urban Development and Respiratory viral infections research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Stroke Rehabilitation and Recovery Rehabilitation 0 works
- 2 Botulinum Toxin and Related Neurological Disorders Neurology 0 works
- 3 Cultural Industries and Urban Development Urban Studies 0 works
- 4 Respiratory viral infections research Epidemiology 0 works
- 5 Assisted Reproductive Technology and Twin Pregnancy Pediatrics, Perinatology and Child Health 0 works
- 6 Reproductive Health and Technologies Reproductive Medicine 0 works
- 7 Reproductive Biology and Fertility Public Health, Environmental and Occupational Health 0 works
- 8 Dermatology and Skin Diseases Dermatology 0 works
- 9 Advanced Drug Delivery Systems Pharmaceutical Science 0 works
- 10 Advancements in Transdermal Drug Delivery Pharmaceutical Science 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Ipsen (Spain)'s research output changed?
Output in 2018–2022 was 7% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Barcelona
- Universitat de Barcelona
- Universitat Politècnica de Catalunya
- Universitat Pompeu Fabra
- Hospital Clínic de Barcelona
- Vall d'Hebron Hospital Universitari
- Hospital de Sant Pau
- Universitat Oberta de Catalunya
- Institució Catalana de Recerca i Estudis Avançats
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.